jRCT2031240538招募中不适用
Pharmacokinetic study of HP-6050 - Investigation of application site -
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 15
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized Controlled Trial
- 干预模型
- Crossover Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 65age old over 至 No limit（—）
- 性别
- All
入选标准
- •Healthy Japanese elderly subjects aged >=65 years
排除标准
- •Subjects with serious cardiovascular, renal, hepatic, neuropsychiatric, or metabolic disease, or with a history of these diseases
- •Subjects who received any drug within 1 week prior to the use of the investigational product
- •Subjects who took any drug considered to affect drug metabolism within 4 weeks prior to the use of the investigational product
结局指标
主要结局
-
Pharmacokinetics, Safety, Pharmacodynamics
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
Pharmacokinetic study of HP-6050Healthy adult and elderlyJPRN-jRCT2031220536Inakura Hiroshi60
已完成
2 期
Single dose pharmacokinetic study of HP-3060Allergic rhinitisJPRN-jRCT2080223788Hisamitsu Pharmaceutical Co., Inc.24
未知
2 期
Single dose pharmacokinetic study of HP-3060Allergic rhinitisJPRN-jRCT2080223009Hisamitsu Pharmaceutical Co., Inc.
已完成
1 期
A single-dose study of HP-6050Healthy adultJPRN-jRCT2031220092Inakura Hiroshi16
未知
1 期
Pharmacokinetic study of DSP-1958pediatric solid tumor, pediatric brain tumor, malignamt lymphomaJPRN-jRCT2080223378Sumitomo Dainippon Pharma Co., Ltd.15